In conclusion, the results of the present study suggested that the background K+ channel K2P5.1 in splenic CD4+ T cells was involved in the pathogenesis of IBD using a chemically-induced IBD model and provided evidence for the K2P5.1 K+ channel as a potential therapeutic target for suppressing the progression of IBD. The gene discussed is KCNK5; the disease is inflammatory bowel disease.